Mesh scandal: lessons from Wall Street ignored

The mesh scandal is all too familiar.1 It joins a growing list of scandals where commercial conflicts of interest (COIs) and effective marketing of a defective product have led to serious injury and loss of life. Against the backdrop of Avandia, Vioxx, Praxil, the opioid crisis, and now the mesh scandal, one wonders what kind of tipping point is needed to prevent a …